FSC
Suppl. Fig. 1. A. B. Isotype. Specific antibody. Albumin. CD146. 200X. CD163. FSC. Suppl. Fig. 2. B. A. C. Suppl. Fig. 3. Suppl. Fig. 4. Suppl. Fig. 5. A. B. RC. DL. SS. % of control. 100 132 138 228 156. Suppl. Fig. 6. U0126 ( M).
FSC
E N D
Presentation Transcript
Suppl. Fig. 1 A B Isotype Specific antibody Albumin CD146 200X CD163 FSC
Suppl. Fig. 2 B A C
Suppl. Fig. 5 A B RC DL SS % of control 100 132 138 228 156
Suppl. Fig. 6 U0126 (M) 0 0.5 1 2 - P2C P3C - P2C P3C - P2C P3C - P2C P3C RC DL SS % of control 100 46 53 113 60 65 166 66 89 194 74 84
Suppl. Fig. 7 A B neg.siRNA lipo2000 siHBx siHBs neg.siRNA lipo2000 siHBx siHBs - P2C P3C - P2C P3C - P2C P3C - P2C P3C pERK RC DL ERK SS C
Suppl. Fig. 9 A B C Mock HBeAg medium HBsAg medium - P2C P3C - P2C P3C - P2C P3C pERK ERK pAkt Akt
Suppl. Fig. 10 P3C 2μg/ml (min) 0 5 30 60 120 15 p-ERK1/2 p-Akt p-p38 p-JNK ERK1/2 β-actin P3C 2μg/ml Cytoplasmic Nucleus (min) 120 120 15 15 0 5 30 60 0 5 30 60 NF-kB p65 -actin
